Literature DB >> 18805965

How I treat rare venous thromboses.

Ida Martinelli1, Massimo Franchini, Pier Mannuccio Mannucci.   

Abstract

Venous thromboembolism may involve venous sites other than the lower limbs, such as cerebral, splanchnic, and upper limb veins. Although uncommon, these thromboses may be clinically severe and challenging for caregivers. In this review, the main pathogenic, clinical, and therapeutic features of thromboses in rare venous sites are discussed. Even though there was a lot of recent progress in understanding the mechanistic role of inherited and acquired thrombophilia and of the interactions between different risk factors, the optimal management of these patients is still unsettled, being currently based on the consensus of experts due to the lack of randomized trials. The implementation of large interdisciplinary registries is a necessary weapon to optimize the treatment of rare venous diseases.

Entities:  

Mesh:

Year:  2008        PMID: 18805965     DOI: 10.1182/blood-2008-07-165969

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Special issues in myeloproliferative neoplasms.

Authors:  Tiziano Barbui; Guido Finazzi
Journal:  Curr Hematol Malig Rep       Date:  2011-03       Impact factor: 3.952

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Cerebral venous sinus thrombosis after allogeneic stem cell transplantation.

Authors:  Kenji Motohashi; Maki Hagihara; Satomi Ito; Takayoshi Tachibana; Hirotaka Takasaki; Masatsugu Tanaka; Atsuo Maruta; Yoshiaki Ishigatsubo; Heiwa Kanamori
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

4.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

Review 5.  Portal vein thrombosis - a primer for the general physician.

Authors:  Mohammad Haris; Jecko Thachil
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

Review 6.  Cerebral sinus-venous thrombosis.

Authors:  Ida Martinelli; Serena Maria Passamonti; Elena Rossi; Valerio De Stefano
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

Review 7.  [Sinus thrombosis and idiopathic intracerebral hypertension: Thrombophilia and hormonal influence as potentially relevant causal connections].

Authors:  Rainer B Zotz
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

8.  The association of active cancer with venous thromboembolism location: a population-based study.

Authors:  Alfonso J Tafur; Henna Kalsi; Waldemar E Wysokinski; Robert D McBane; Aneel A Ashrani; Randolph S Marks; Daniel J Crusan; Tanya M Petterson; Kent R Bailey; John A Heit
Journal:  Mayo Clin Proc       Date:  2011-01       Impact factor: 7.616

9.  Deficiencies of proteins C, S and antithrombin and activated protein C resistance--their involvement in the occurrence of Arterial thromboses.

Authors:  Angela Mirela Soare; Constantin Popa
Journal:  J Med Life       Date:  2010 Oct-Dec

10.  JAK2V617F: Is It Sufficient as a Single Player in Splanchnic Venous Thrombosis?

Authors:  Pratibha Dhiman; Priyanka Saxena
Journal:  Case Rep Hematol       Date:  2015-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.